Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.
Estrogen (ER) and progesterone receptor (PR) contents in primary tumors from 127 advanced breast cancer patients were measured by DCC method. The patients were followed for 2 years and the prognostic value of the receptor levels was evaluated and compared with other tumor and patient characteristics. No relation was found between receptor levels and tumor, first relapse site as well as short-term survival (2 years) which might be due to the advanced stage of disease at diagnosis.
Bhatavdekar
J M
JM
Division of Research, Gujarat Cancer Society, Asarwa, Ahmedabad, India.
Patel
D D
DD
Karelia
N H
NH
Trivedi
S N
SN
Shah
N G
NG
Vora
H H
HH
Ghosh
N
N
Balar
D B
DB
D000328:Adult; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000737:chemistry* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000401:mortality / Q000473:pathology; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*; D012983:Soft Tissue Neoplasms / Q000556:secondary
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone